Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Larimar appointed John B. Harlow, Jr. as President and Chief Operating Officer, effective September 29, 2026.Original SEC Filing: Larimar Therapeutics, Inc. [ LRMR ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the so…
John Harlow is named president and chief operating officer at Larimar Therapeutics, effective Sept. 29, 2026, reporting to CEO Carole Ben-Maimon.
Larimar Therapeutics appointed John Harlow as President and Chief Operating Officer, effective Sept. 29, 2026. An inducement grant includes options for 800,000 shares and 50,000 RSUs, vesting over four years.Material DetailsContext by AI AnalystThis is a late-stage scaling move as Larimar readies n…
Larimar Therapeutics strengthens its executive leadership by appointing John Harlow as President and Chief Operating Officer.